Zaccardi F, Kloecker DE, Khunti K, Davies MJ, et al. Noninferiority and clinical superiority of GLP-1 receptor agonists and SGLT2 inhibitors: systematic analysis of cardiorenal outcome trials in type 2 diabetes. Diabetes Obes Metab 2022 May 1. doi: 10.1111/dom.14735.
PMID: 35491523